MedTrace Logo

Cardiac Functions in Living Donor Liver Transplant Recipients. An Echocardiographic Study.

NCT01840514 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2013-10-08

No results posted yet for this study

Summary

The stress of orthotopic living donor liver transplantation in patients with cirrhosis could induce worsening of an already recorded myocardial dysfunction or may be associated with a new myocardial dysfunction in patients previously having normal myocardial functions, therefore this study will be designed for intra-operative detection of new onset ventricular dysfunction or worsening of already diagnosed ventricular dysfunction in living donor liver transplant recipient and the possible contribution of several hemodynamic and oxygenation parameters in the generation of any cardiovascular function impairment will be also investigated and to determine the impact of ventricular dysfunction on early (7 PO days) graft function, 28 days survival and patient outcomes.

Conditions

  • Liver Transplant

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • amr yassen, MD · Liver transplant program, mansoura faculty of medicine

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2015-04-30
Completion
2015-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01840514 on ClinicalTrials.gov